Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

21
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
21
Mitral Regurgitation III: Medical Management01:25

Mitral Regurgitation III: Medical Management

30
Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
30
Mitral Valve Prolapse II: Assessment and Management01:22

Mitral Valve Prolapse II: Assessment and Management

39
IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular...
39
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

34
Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
34
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

37
Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
37
Mitral Regurgitation II: Clinical Features and Diagnostic Tests01:23

Mitral Regurgitation II: Clinical Features and Diagnostic Tests

51
Mitral regurgitation (MR) is a valvular heart disorder in which the mitral valve fails to close tightly, allowing blood to leak backward into the heart. Understanding the clinical manifestations, assessment, diagnostic findings, and medical management of MR is crucial to effectively managing affected patients.Clinical Manifestations of Mitral RegurgitationMitral regurgitation can be acute or chronic, each presenting differently and requiring different approaches:1. Acute Mitral...
51

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Indications and outcomes of non-emergent cardiac surgery following transcatheter aortic valve replacement.

Interdisciplinary cardiovascular and thoracic surgery·2026
Same author

An Evaluation of Pediatric Dermatology Fellowship Websites: Content Analysis and Perspectives of Fellows and Program Directors.

Pediatric dermatology·2026
Same author

Non-bacterial thrombotic endocarditis and intraventricular small-vessel thromboembolic occlusion mimicking immune checkpoint inhibitor myocarditis in a patient treated with pembrolizumab: a case report.

European heart journal. Case reports·2026
Same author

Does the genotype of hypertrophic cardiomyopathy impact the outcomes of septal myectomy?

The Journal of thoracic and cardiovascular surgery·2026
Same author

Deep Learning-Derived Body Composition Analysis Predicts Long-Term Mortality After Transcatheter Aortic Valve Replacement.

Mayo Clinic proceedings. Digital health·2026
Same author

Reply: From risk marker to decision support: Artificial intelligence electrocardiogram age in coronary artery bypass grafting.

The Journal of thoracic and cardiovascular surgery·2026

相关实验视频

Updated: Sep 10, 2025

A Simplified Stepwise Approach to Echo Guidance during Percutaneous Mitral Valve Repair
08:31

A Simplified Stepwise Approach to Echo Guidance during Percutaneous Mitral Valve Repair

Published on: October 16, 2021

4.0K

跨导管边缘修复与八代人中中枢手术:安全性,耐久性和生存的比较分析

Sina Danesh1, Hartzell V Schaff1, Kimberly A Holst1

  • 1Department of Cardiovascular Surgery, Mayo Clinic, Rochester, Minnesota, USA.

The Journal of thoracic and cardiovascular surgery
|August 23, 2025
PubMed
概括

与过导管端到端修复相比,八岁以上的患者的中枢手术提供了更好的长期存活率和更少的复发性中枢反 (MR). 然而, TEER 与住院时间缩短和并发症减少有关.

关键词:
中心的反年长的患者剩余的 mitra 吐跨导管边缘修复 (TEER)

更多相关视频

Fully Endoscopic Mitral Valve Repair with Percutaneous Cannulation of Groin Vessels
08:12

Fully Endoscopic Mitral Valve Repair with Percutaneous Cannulation of Groin Vessels

Published on: May 26, 2023

1.8K
Standardized Technique of Aortic Valve Re-implantation for Valve-sparing Aortic Root Replacement
14:14

Standardized Technique of Aortic Valve Re-implantation for Valve-sparing Aortic Root Replacement

Published on: December 11, 2017

14.2K

相关实验视频

Last Updated: Sep 10, 2025

A Simplified Stepwise Approach to Echo Guidance during Percutaneous Mitral Valve Repair
08:31

A Simplified Stepwise Approach to Echo Guidance during Percutaneous Mitral Valve Repair

Published on: October 16, 2021

4.0K
Fully Endoscopic Mitral Valve Repair with Percutaneous Cannulation of Groin Vessels
08:12

Fully Endoscopic Mitral Valve Repair with Percutaneous Cannulation of Groin Vessels

Published on: May 26, 2023

1.8K
Standardized Technique of Aortic Valve Re-implantation for Valve-sparing Aortic Root Replacement
14:14

Standardized Technique of Aortic Valve Re-implantation for Valve-sparing Aortic Root Replacement

Published on: December 11, 2017

14.2K

科学领域:

  • 心脏病学
  • 干预心脏病学
  • 心脏外科

背景情况:

  • 在80岁及以上的患者中,很少有实验性研究比较过导管边缘修复 (TEER) 和 mitraleplepleplepleplepleplepleplepleplepleplepleplepleplepleplepleplepleplep
  • 由于并发症和虚弱性,八岁以上人群中腹的管理具有独特的挑战.

研究的目的:

  • 为了比较80岁或以上的患者的手术和透管干预的短期和长期结果.
  • 在八十多岁的人群中评估TEER与MV手术的安全性和有效性.

主要方法:

  • 在2014年至2024年间,对744名80岁以上接受MV手术或TEER的病人的回顾性分析.
  • 在排除了额外手术或MV狭窄的患者后,创建了252名患者 (126例手术,126例TEER) 的1:1倾向度匹配队列.

主要成果:

  • 三十天死亡率在各组之间是相似的 (1.6%的手术与0. 8%的TEER).
  • 手术修复与较少的残留MR (2.4%与8%相比),较少的三角吐 (10.5%与50%相比) 和较低的RV静脉压 (37.5与44mmHg相比) 相关.
  • 在中位数为3. 9年的随访期内,手术显示复发性MR较低 (6. 4%与33. 3%相比),五年生存率更高 (68%与56%相比).

结论:

  • 对于80岁以上的MR患者来说,MV手术和TEER都是可行的.
  • 尽管术后并发症和住院时间较长,但MV手术在复发性MR和生存方面提供了优异的长期结果.
  • 在医院住院时间缩短和与手术相关的并发症减少方面,TEER具有优势.